Magnesium hypophosphite | CAS:10377-57-8

We serve Magnesium hypophosphite CAS:10377-57-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Magnesium hypophosphite

Synonyms:
Diphosphinic acid magnesium salt
Phosphinic acid,magnesium salt
magnesium phosphinate
 
Molecular Formula: MgO4P2
Molecular weight:150.25000
 
 
Density: 1.59g/cm3
 
Items of Analysis Standard of Analysis Test Results
Appearance White crystal or powder Conform
Assay ≥98% 98.35%
Arsen ≤4 ppm 2.6 ppm
Lead ≤1 ppm 0.36 ppm
Insolubles ≤0.5% 0.34%
Water content ≤0.5% 0.20%
Fe ≤500 ppm 300 ppm
pH 3-6 5.14
Conclusion Conforms to Factory Standard
 




Contact us for information like Magnesium hypophosphite chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,magnesium phosphinate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,magnesium phosphinate Use and application,Magnesium hypophosphite technical grade,usp/ep/jp grade.


Related News: Beta Bionics is committed to obtaining regulatory approval and commercializing all three iLet configurations.Glycyl-L-Leucine manufacturer However, compared with the 60-70% refinement rate in developed economies such as North America, Western Europe, and Japan, China is still only equivalent to the level of the United States in the 1980s. There is still a lot of room for improvement in China’s refinement rate. period.[tert-butoxycarbonylimino-(2-oxa-3-aza-bicyclo[2.2.2]oct-3-yl)methyl]-carbamic acid tert-butyl ester supplier However, compared with the 60-70% refinement rate in developed economies such as North America, Western Europe, and Japan, China is still only equivalent to the level of the United States in the 1980s. There is still a lot of room for improvement in China’s refinement rate. period.1-[(2-Methoxynaphth-3-yl)-N-ethylaminocarbonyl]-4-(3,5-dimethoxyphenyl)piperazine vendor Bulk bulk medicines: overcapacity, low prices, future capacity and output will be reduced, and it is possible to transfer foreign production.The ban will be in place for up to 14 days, and is aimed at helping contain the spread of the Wuhan coronavirus. So far, there have been no confirmed coronavirus cases in New Zealand or any South Pacific island.